Novel cord blood transplant therapies. - Wikidata - awgldk - TriplyDB

Novel cord blood transplant therapies.

Novel cord blood transplant therapies.

http://www.wikidata.org/entity/Q37800641

about

How to Improve Cord Blood Engraftment?Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.The expanding frontier of hematopoietic cell transplantation.Distribution of CD4+ CD25 high FoxP3+ regulatory T-cells in umbilical cord blood.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice

P2860

Q26765622-400CD754-9740-4DA9-A58D-318D62EEC943 Q30423085-BA1C918F-0E2C-4B46-97B0-488ED97B9B1D Q35845470-81C35A1A-89FE-4C3E-8EE5-7A491F363DE5 Q36305254-F551B0BF-3C4C-488E-BFA7-870F52193AD9 Q38032255-DC2B9DCD-598F-4797-BDB3-405E768E2302 Q38465260-B0DFD4DE-F642-4DA3-AC71-4C5D5BB70822 Q41411372-1AE1D0BD-1980-4BDE-AD0B-CA438B3C4879 Q42715456-7ED47B5B-262C-4977-98BA-5A32C9737664

P2860

Novel cord blood transplant therapies.

http://www.wikidata.org/entity/Q37800641

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel cord blood transplant therapies.

@en

Novel cord blood transplant therapies.

@nl

type

label

Novel cord blood transplant therapies.

@en

Novel cord blood transplant therapies.

@nl

prefLabel

Novel cord blood transplant therapies.

@en

Novel cord blood transplant therapies.

@nl

P1433

Q37800641-6E2E4CF9-DCED-4A5A-937D-9131F6A3B556

P1476

Q37800641-AFE5BAA5-1B9C-409A-BE7C-EB709CBD21B0

P2093

Q37800641-1BF228AB-88F2-471E-8CC7-68D07CD3C63E

Q37800641-513411F8-6E24-4266-8EB7-A685045CFD3F

Q37800641-DCEECB5C-F822-477C-9E1F-02F297BACC33

P2860

Q37800641-09EB2165-92F5-4BDB-B5BA-EBEB7427DE78

Q37800641-0B1981AA-3278-4800-B5BB-DAA530853DBD

Q37800641-16544850-0688-427A-85DD-71CEA82D5E86

Q37800641-1EF412E6-58B6-4908-B5C6-558E38DCC477

Q37800641-47D17593-8783-47F3-BE1B-FB7DB36F419A

Q37800641-5136EC80-B3A0-42AC-9192-817DBF87868E

Q37800641-68A87ABC-BD32-4251-8C3F-369595F2D40B

Q37800641-69128BC8-572E-4075-98A3-5CDC21895918

Q37800641-7A8EB78B-E1A1-4D91-BB62-498F5165702B

Q37800641-8EFF46B0-9816-43D7-A6FC-D44BCAF04C48

P304

Q37800641-C5C5ADFA-FC35-456C-887D-5601ABD3C684

P31

Q37800641-5033942F-CA9B-460C-B644-50D96B0314ED

P356

Q37800641-5349C061-E569-4B81-ABD1-D0BF0A03B6A8

P433

Q37800641-888D4960-8E9A-4135-8EC8-ECC4773F48C6

P478

Q37800641-BE40C04F-DE6C-4C6F-8903-DFFB253316D3

P577

Q37800641-60516D41-40B6-4D61-95B7-3853FA092865

P5875

Q37800641-89C6C191-CB18-42F6-B343-5475814BBFA9

P698

Q37800641-F1464C3A-D4F6-4D36-A16A-A41F33D7E580

P932

Q37800641-FF438021-6273-4F62-BA5A-24D92D3F045B

P356

J.BBMT.2010.10.004

P1433

Biology of Blood and Marrow Transplantation

P1476

Novel cord blood transplant therapies.

@en

P2093

Catherine M Bollard

http://www.w3.org/2001/XMLSchema#string

Claudio Brunstein

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

P2860

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Targeting tumours with genetically enhanced T lymphocytes.

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

P304

S39-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.10.004

http://www.w3.org/2001/XMLSchema#string

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47449127

http://www.w3.org/2001/XMLSchema#string

P698

20951821

http://www.w3.org/2001/XMLSchema#string

P932

4213144

http://www.w3.org/2001/XMLSchema#string